Views for Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
Total visits
views | |
---|---|
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. | 340 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Succop_Stacey_M_2014.pdf | 182 |
Succop_Stacey_M_2014.pdf(legacy) | 31 |
Top country views
views | |
---|---|
United States | 137 |
South Africa | 58 |
Sweden | 26 |
Germany | 25 |
Netherlands | 25 |
China | 9 |
Vietnam | 9 |
Finland | 8 |
Ireland | 8 |
Singapore | 5 |
Russia | 4 |
Canada | 3 |
India | 3 |
South Korea | 2 |
Turkey | 2 |
Austria | 1 |
Brazil | 1 |
Estonia | 1 |
Iraq | 1 |
Moldova | 1 |
Ukraine | 1 |
Top city views
views | |
---|---|
Ashburn | 65 |
Johannesburg | 25 |
Hanoi | 9 |
Dublin | 8 |
Des Moines | 7 |
Washington | 5 |
Andover | 4 |
Durban | 4 |
Bengaluru | 3 |
Cape Town | 3 |
Mountain View | 3 |
Pretoria | 3 |
Secaucus | 3 |
Honeydew | 2 |
Istanbul | 2 |
Santa Clara | 2 |
Seattle | 2 |
Singapore | 2 |
Tzaneen | 2 |
Beijing | 1 |
Brooklyn | 1 |
Chengdu | 1 |
Chuzhou | 1 |
Heidelberg | 1 |
Nanchang | 1 |
Phoenix | 1 |
Stellenbosch | 1 |
Valencia | 1 |
Vienna | 1 |